heptapeptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-10-17. Numbers and descriptions here follow the published literature rather than marketing material.
Development is attributed to researchers at the Institute of Molecular Genetics in Moscow during the early 1980s, building on earlier Soviet work with ACTH fragments. Russian regulatory approval followed for intranasal use, and the compound has remained commercially available there for decades. Most published human data originate from Russian and, later, some Eastern European clinical reports, which are not always accessible in English translation. Outside that region the material is generally handled as a research chemical rather than a licensed medicine.
Regulatory status differs sharply between jurisdictions. In Russia the peptide is registered as a prescription nasal preparation, while agencies such as the United States Food and Drug Administration have not approved it for any indication. Products sold elsewhere are typically labeled for laboratory research only, and such labels shift responsibility for safe handling to the purchaser. Because the same name covers pharmaceutical-grade nasal drops and bulk research powder, identity and purity documentation becomes the main practical concern when comparing sources.
Identity and purity are established with standard peptide methods. Reversed-phase HPLC with ultraviolet detection near 214 nm resolves the parent peak from deletion and truncation byproducts, and reports typically quote a main-peak percentage. Mass spectrometry by electrospray or MALDI-TOF confirms the expected molecular mass, while amino acid analysis or peptide mapping can verify composition when the sequence itself is in question. A certificate of analysis that pairs a chromatogram with a mass spectrum is more informative than a purity figure alone. Counter-ion content and residual solvents are separate specifications and are frequently omitted.
Semax is normally supplied as a lyophilized powder, and that form is the most stable. Suppliers commonly recommend storage at -20 °C in a desiccated container protected from light, with short-term handling at room temperature limited to weighing and transfer. Powder that has absorbed moisture degrades faster, so vials should be warmed to ambient temperature before opening to prevent condensation on the contents. Hygroscopic behavior is typical of short hydrophilic peptides, and humidity control matters more than temperature alone for long-term retention.
Once dissolved, the peptide is considerably less stable than the solid. Aqueous solutions are usually prepared at neutral to slightly acidic pH, filtered, and divided into single-use aliquots before freezing. Repeated freeze-thaw cycles are a common cause of avoidable loss and are best prevented by never refreezing a thawed aliquot. Adsorption to plastic and glass surfaces can lower the measured concentration of dilute solutions, particularly below roughly 0.1 mg/mL. Buffer choice, salt content, and container material all influence how much peptide remains detectable after storage.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic heptapeptide (ACTH fragment analog) | Not a steroid; does not belong to the melanocortin agonist drugs by marketing category |
| Molecular formula | C37H51N9O10S (commonly cited) | Reported values vary slightly with salt and counter-ion content |
| Appearance | White to off-white lyophilized powder | A single batch may appear as a loose cake or fluffy solid |
| Solubility | Freely soluble in water and aqueous buffer | Stock solutions are usually prepared in sterile water or saline |
| Typical storage | −20 °C or below, desiccated and protected from light | Seal opened vials promptly to limit moisture uptake |
Development took place during the 1980s at institutes of the Russian Academy of Sciences, where peptide fragments of ACTH were screened for cognitive and neuroprotective effects. The compound received regulatory approval in Russia as a nasal preparation, marketed for conditions such as ischemic stroke, transient ischemic attacks, and optic nerve disorders. Registration in other countries has not followed. Most published clinical reports originate from a small number of Russian research groups, and independent replication outside that setting remains limited. The regulatory status therefore differs sharply between Russia and the rest of the world.
Laboratory work points toward modulation of neurotrophic signaling, particularly expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal tissue. Studies also describe effects on monoamine turnover, inflammatory mediators, and oxidative markers. These observations come mainly from animal models and cultured cells, so the causal chain in humans is not firmly established. Whether the reported molecular changes translate into measurable clinical benefit is an open question. Reviews generally present the mechanism as plausible rather than demonstrated.
Proposed mechanisms center on neurotrophic signaling rather than on classical melanocortin receptor activation. Rodent experiments have reported shifts in the expression of brain-derived neurotrophic factor and nerve growth factor after administration, together with changes in the associated receptor systems. Several authors argue that the peptide acts largely through its degradation products and their interaction with peptidergic pathways, but this remains a hypothesis rather than a settled finding. No single molecular target has been identified in a way that the field broadly accepts.
Published research covers ischemic stroke, traumatic brain injury, cognitive impairment, optic nerve conditions and attention-related measures. Much of the human evidence comes from small trials conducted in one country, which limits how far the results generalize. Animal models supply the larger share of the data, and effects seen in rodents do not transfer automatically to people. Reviews have noted that methodological reporting is often incomplete, making it difficult to pool results or compare treatment schedules across studies.
For services to the community in Radley, Oxfordshire. Robert Frank Earl. For services to the community in Radley, Oxfordshire. Christopher Harry Wrenn Eaton. For services to the community in Wakes Colne, Essex. Euros Hefin Edwards. Watch Manager, Mid and West Wales Fire and Rescue Service. For services to Fire and Rescue. Greta Edwards. Cleaner and Kitchen Assistant, North Shore Academy, Stockton-on-Tees. For services to Education. Llinos Edwards. Lately Nurse Team Leader, The Looked After Children Team, Betsi Cadwaladr University Health Board. For services to Vulnerable Children in North Wales. Stephen David Elsden. Chief Executive, Compaid Trust. For services to Charity and to People with Disabilities. Robert Felix Erith TD DL. For services to the Environment in Dedham Vale, Essex and Suffolk. Sandra Mary Esqulant. For services to the community in Spitalfields, London Borough of Tower Hamlets. Annabel Whyte Evans. For services to the community in Chesham, Buckinghamshire. Lyndsey Claire Evans. For services to the community in South Wye, Herefordshire. Marian Louise Evans. For services to Business. Edward Everett. Member, Friends of Bridgwater Canal. For services to the Environment in Sale, Metropolitan Borough of Trafford. John Fielding. Scout Leader, 2nd Rishton Baptist Scout Group, Lancashire. For services to Young People and to the community in Lancashire. Mabel Elsie Finnigan. County Captain, Shropshire Ladies Bowls Team. For services to Bowls. Mary Margaret Rose Fisher. Lately Lollipop Crossing Patrol, Darley and Summerbridge Community Primary School, Harrogate.
Mass change = (unbound system calculated mass) − (measured mass of system) e.g. (sum of masses of protons and neutrons) − (measured mass of nucleus) After a nuclear reaction occurs that results in an excited nucleus, the energy that must be radiated or otherwise removed as binding energy in order to decay to the unexcited state may be in one of several forms. This may be electromagnetic waves, such as gamma radiation; the kinetic energy of an ejected particle, such as an electron, in internal conversion decay; or partly as the rest mass of one or more emitted particles, such as the particles of beta decay. No mass deficit can appear, in theory, until this radiation or this energy has been emitted and is no longer part of the system. When nucleons bind together to form a nucleus, they must lose a small amount of mass, i.e. there is a change in mass to stay bound. This mass change must be released as various types of photon or other particle energy as above, according to the relation E = mc2. Thus, after the binding energy has been removed, binding energy = mass change × c2. This energy is a measure of the forces that hold the nucleons together. It represents energy that must be resupplied from the environment for the nucleus to be broken up into individual nucleons. For example, an atom of deuterium has a mass defect of 0.0023884 Da, and its binding energy is nearly equal to 2.23 MeV. This means that energy of 2.23 MeV is required to disintegrate an atom of deuterium.
== Estimation methods == The basic reproduction number can be estimated through examining detailed transmission chains or through genomic sequencing. However, it is most frequently calculated using epidemiological models. During an epidemic, typically the number of diagnosed infections
Progress in Engineering Application and Technology. 2 (2): 732–751. eISSN 2773-5303. Archived from the original on 1 June 2025 – via Universiti Tun Hussein Onn. Pahrurodji, Purwanti (6 August 2021). Dari Dapur Rumput Laut: Makananmu adalah Obatmu dan Obatmu adalah Makananmu [From the Kitchen of Seaweed: Your Food is Your Medicine and Your Medicine is Your Food] (in Indonesian). Pimedia. ISBN 978-623-6488-06-5. A. Jalalal, Syamimi (2022). EFFICACY OF COMMERCIAL GAMAT EXTRACT (Stichopus variegatus) PREPARATION ON STRAY CATS WITH GASTROINTESTINAL HELMINTHIASIS. Degree of Doctor of Veterinary Medicine (Thesis) (in Malay). pp. 1–112. Archived (PDF) from the original on 2 June 2025. Retrieved 2 June 2025 – via Universiti Malaysia Kelantan. Alpayet, Rahmat; Andi Mustika, Aulia; Rahma, Anisa; Andriyanto, Andriyanto; Noviyanti Sutardi, Lina (2023). "Penyembuhan luka sayatan menggunakan krim ekstrak teripang laut dan kunyit" [Healing of incision wound using sea cucumber and turmeric extracts cream]. Current Biomedicine (in Indonesian). 1 (2): 732–751. doi:10.29244/currbiomed.1.2.54-61. eISSN 2985-4784. Archived from the original on 1 June 2025 – via IPB University, Bogor, Indonesia.
Jollibee offers American-influenced fast food items and casual Filipino fare. Among the establishment's best sellers are the Yumburger, the house hamburger first introduced during their early days of operation; the Chickenjoy, a fried chicken meal, introduced in the 1980s, with regular and spicy versions; and Jolly Spaghetti, a sweet Filipino spaghetti that includes a beef sauce with pieces of hot dog and ham. In 1995, Jollibee introduced the Burger Steak to its menu. At its international locations, Jollibee also offers localized products, such as chili chicken in Vietnam and nasi lemak in Brunei. Jollibee serves Coca-Cola products in Luzon and Visayas and Pepsi products in Mindanao and its overseas markets.
Sources: en.wikipedia.org
=== Cancer === HLA-G has been shown to be associated with tumor escape in cancers, because it causes the immune system to not pay attention to cancer cells. Because it is upregulated in cancer cells, it could serve as a potential target for immunotherapy. Monoclonal antibodies that bind to HLA-G have been used successfully against cancers as part of a strategy to inhibit immune checkpoints. HLA-G has potential utility as a tumor marker due to the large increase in HLA-G in many cancers, including breast cancer, ovarian cancer, and lung cancer. Increased expression of HLA-G has been associated with the metastatic potential of tumor cells.
==== Cell surface receptors ==== The extracellular environment is able to induce changes within the cell. Hormones, or other extracellular signals, are able to induce changes within the cell by binding to cell surface receptors also known as transmembrane receptors. This interaction allows the hormone receptor to produce second messengers within the cell to aid response. Second messengers may also be sent to interact with intracellular receptors in order to enter the complex signal transport system that eventually changes cellular function. G-protein-coupled membrane receptors (GPCR) are a major class of transmembrane receptors. The features of G proteins include GDP/GTP binding, GTP hydrolysis and guanosine nucleotide exchange. When a ligand binds to a GPCR the receptor changes conformation, which makes the intracellular loops between the different membrane domains of the receptor interact with G proteins. This interaction causes the exchange of GDP for GTP, which triggers structural changes within the alpha subunit of the G protein. The changes interrupts the interaction of the alpha subunit with the beta–gamma complex and which results in a single alpha subunit with GTP bound and a beta–gamma dimer. The GTP–alpha monomer interacts with a variety of cellular targets. The beta–gamma dimer also can stimulate enzymes within the cells for example, adenylate cyclase but it does not have as many targets as the GTP–alpha complex.
=== Overview === Undeterred by opposition, the Meiji leaders continued to modernize the nation through government-sponsored telegraph cable links to all major Japanese cities and the Asian mainland and construction of railroads, shipyards, munitions factories, mines, textile manufacturing facilities, factories, and experimental agriculture stations. Greatly concerned about national security, the leaders made significant efforts at military modernization, which included establishing a small standing army, a large reserve system, and compulsory militia service for all men. Foreign military systems were studied, foreign advisers, especially French ones, were brought in, and Japanese cadets sent abroad to Europe and the United States to attend military and naval schools.
=== Learning and memory === The first learning and memory mutants (dunce, rutabaga, etc.) were isolated by William "Chip" Quinn while in Benzer's lab, and were eventually shown to encode components of an intracellular signaling pathway involving cyclic AMP, protein kinase A, and a transcription factor known as CREB. These molecules were shown to be also involved in synaptic plasticity in Aplysia and mammals. The initial report by William Quinn et al. described a basic conditioned preference assay. Over the next decade, the assay evolved into the classical olfactory conditioning paradigm in the T-maze: ~100 flies in a vial are connected to a short hallway that splits in two directions, a T-maze. On either end of the T-maze are two odors that are initially neutral, i.e. flies do not show preference for one odor or the other. The assay involves counting the number of flies in each side of the T-maze corridor. Before training half of the flies, on average, will before in each end. During training, the flies also encounter a stimulus in one of the two ends, typically either a sugar reward or an electric shock. After training, flies will show a preference for one odor or another. The two odors are referred to as the conditioned stimulus (CS), and the reward is the unconditioned stimulus (US). The T-maze assay was used to show where in the fly brain the association is made between the unconditioned stimulus and the conditioned stimulus. Olfactory sensory information is carried by antennal lobe projection neurons to the Kenyon cells of the mushroom body of the fly brain.
Sources: en.wikipedia.org
It is a short synthetic peptide built from seven amino acids: methionine, glutamic acid, histidine, phenylalanine and three prolines. The sequence derives from the 4-10 fragment of adrenocorticotropic hormone with an added proline-glycine-proline tail. No plant or animal extract is involved; the material is produced by solid-phase peptide synthesis.
It was developed in the Soviet Union during the early 1980s by groups at the Institute of Molecular Genetics in Moscow. Russian approval for intranasal use followed, and it has been marketed there since. Western laboratories encountered it mainly through translated literature and, later, through online research-chemical trade.
It holds a Russian registration as a prescription nasal product but has no approval from the European Medicines Agency or the United States Food and Drug Administration. Buyers outside Russia usually receive material sold strictly for laboratory research. That distinction matters because research-grade and pharmaceutical-grade products carry different documentation and testing expectations.
Each freeze-thaw cycle can degrade a fraction of the peptide and promote aggregation. Dividing a stock solution into single-use volumes removes repeated cycling as a variable. It also limits the time a thawed solution spends at room temperature.